Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Other Non-Current Liabilities: 2019-2024

Historic Other Non-Current Liabilities for CureVac N.V (CVAC) over the last 6 years, with Dec 2024 value amounting to $31.6 million.

  • CureVac N.V's Other Non-Current Liabilities rose 22.94% to $41.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $41.1 million, marking a year-over-year increase of 22.94%. This contributed to the annual value of $31.6 million for FY2024, which is 42.14% down from last year.
  • Latest data reveals that CureVac N.V reported Other Non-Current Liabilities of $31.6 million as of FY2024, which was down 42.14% from $54.6 million recorded in FY2023.
  • CureVac N.V's 5-year Other Non-Current Liabilities high stood at $62.6 million for FY2022, and its period low was $302,008 during FY2021.
  • Its 3-year average for Other Non-Current Liabilities is $49.6 million, with a median of $54.6 million in 2023.
  • As far as peak fluctuations go, CureVac N.V's Other Non-Current Liabilities plummeted by 42.17% in 2020, and later soared by 20,615.18% in 2022.
  • CureVac N.V's Other Non-Current Liabilities (Yearly) stood at $338,610 in 2020, then fell by 10.81% to $302,008 in 2021, then surged by 20,615.18% to $62.6 million in 2022, then decreased by 12.78% to $54.6 million in 2023, then plummeted by 42.14% to $31.6 million in 2024.